Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2β) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: Implications for prevention trials

Diabetologia

Volumn 53, Issue 3, 2010, Pages 517-524

  De Grijse, J ^a   Asanghanwa, M ^a   Nouthe, B ^a   Albrecher, N ^b   Goubert, P ^a,b   Vermeulen, I ^a   Van Der Meeren, S ^b   Decochez, K ^a,b   Weets, I ^a,b   Keymeulen, B ^a,b   Lampasona, V ^c   Wenzlau, J ^d   Hutton, J C ^d   Pipeleers, D ^a   Gorus, F K ^a,b  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Autoantibodies; HLA DQ; IA 2; IA 2 ; Prediction; Type 1 diabetes; Zinc transporter 8

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULINOMA ASSOCIATED PROTEIN 2 BETA; UNCLASSIFIED DRUG; ZINC TRANSPORTER 8; CATION TRANSPORT PROTEIN; HLA DQ ANTIGEN; INSULIN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; SLC30A2 PROTEIN, HUMAN; ZINC;

ADULT; ANTIBODY SCREENING; ARTICLE; DIABETIC PATIENT; DISEASE COURSE; GENOTYPE; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGISTER; ADOLESCENT; BIOSYNTHESIS; CHEMISTRY; CHILD; FAMILY HEALTH; FEMALE; GENETICS; MALE; METABOLISM; PREDICTIVE VALUE;

ADOLESCENT; ADULT; AUTOANTIBODIES; CATION TRANSPORT PROTEINS; CHILD; DIABETES MELLITUS, TYPE 1; FAMILY HEALTH; FEMALE; HLA-DQ ANTIGENS; HUMANS; INSULIN; MALE; PREDICTIVE VALUE OF TESTS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; ZINC;

EID: 77949273351     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1618-y     Document Type: Article

References (32)

1. B Keymeulen E Vandemeulebroucke A Ziegler, et al. 2005 Insulin needs following CD3-antibody therapy in new-onset type 1 diabetes N Engl J Med 352 2598 2608 10.1056/NEJMoa043980 1:CAS:528:DC%2BD2MXls1Wqu7k%3D 15972866 (Pubitemid 41007846)
2. E Vandemeulebroucke B Keymeulen K Decochez, et al. 2009 Hyperglycaemic clamp test for diabetes risk assessment in IA-2 antibody-positive relatives of type 1 diabetic patients Diabetologia 10.1007/s00125-009-1569-3 19898832
3. L Chatenoud E Thervet J Primo JF Bach 1994 Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice Proc Natl Acad Sci USA 91 123 127 10.1073/pnas.91.1.123 1:CAS:528:DyaK2cXnsFehuw%3D%3D 8278351 (Pubitemid 24018655)
4. FK Gorus DG Pipeleers 2001 Prospects for predicting and stopping the development of type 1 diabetes Best Pract Res Clin Endocrinol 15 371 389 10.1053/beem.2001.0152 1:CAS:528:DC%2BD38Xhs1OmtQ%3D%3D (Pubitemid 32916268)
5. CF Verge R Gianani E Kawasaki, et al. 1996 Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA 512bdc/IA-2 autoantibodies Diabetes 45 926 933 10.2337/diabetes.45.7.926 1:CAS:528:DyaK28Xkt1Wqs70%3D 8666144
6. P Kulmala K Savola JS Petersen, et al. 1998 Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes J Clin Invest 101 327 336 10.1172/JCI119879 1:CAS:528:DyaK1cXmtF2isg%3D%3D 9435304
7. AL Notkins Å Lernmark 2001 Autoimmune type 1 diabetes: resolved and unresolved issues J Clin Invest 108 1247 1252 1:CAS:528:DC%2BD3MXot12ksb8%3D 11696564
8. PJ Bingley EA Gale 2006 Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk Diabetologia 49 881 890 10.1007/s00125-006-0160-4 1:STN:280: DC%2BD283jsVWjtg%3D%3D 16514546
9. FK Gorus P Goubert C Semakula, et al. 1997 IA-2 autoantibodies complement GAD65-autoantibodies in new onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry Diabetologia 40 95 99 10.1007/s001250050648 1:CAS:528:DyaK2sXmvFamug%3D%3D 9028724 (Pubitemid 27035716)
10. K Decochez I De Leeuw B Keymeulen, et al. 2002 IA-2 autoantibodies predict impending type 1 diabetes in siblings of patients. The Belgian Diabetes Registry Diabetologia 45 1658 1666 10.1007/s00125-002-0949-8 1:CAS:528:DC%2BD38XpsFOmsL4%3D 12488955 (Pubitemid 35478135)
11. P Achenbach K Warncke J Reiter, et al. 2004 Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics Diabetes 53 384 392 10.2337/diabetes.53.2.384 1:CAS:528:DC%2BD2cXhtlWhu74%3D 14747289 (Pubitemid 38174554)
12. P Achenbach E Bonifacio AJ Williams, et al. 2008 Autoantibodies to IA-2 beta improve diabetes risk assessment in high-risk relatives Diabetologia 51 488 492 10.1007/s00125-007-0912-9 1:CAS:528:DC%2BD1cXhtlyls7g%3D 18193190
13. JM Wenzlau K Juhl L Yu, et al. 2007 The cation efflux transporter ZnT8A (Sec 30A8) is a major autoantigen in human type 1 diabetes Proc Natl Acad Sci USA 104 17040 17045 10.1073/pnas.0705894104 1:CAS:528:DC%2BD2sXht1KgtLfM 17942684 (Pubitemid 350210987)
14. JM Wenzlau Y Liu L Yu, et al. 2008 A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes Diabetes 57 2693 2697 10.2337/db08-0522 1:CAS:528:DC%2BD1MXhs1Kntrw%3D 18591387
15. E Kawasaki M Uga K Nakamura, et al. 2008 Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes Diabetologia 51 2299 2302 10.1007/s00125-008-1165-y 1:CAS:528:DC%2BD1cXhtlCjs7zN 18850084
16. K Decochez I Truyen B Van der Auwera, et al. 2005 Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes Diabetologia 48 687 694 10.1007/s00125-005-1702-x 1:CAS:528:DC%2BD2MXjtlGhs7g%3D 15756536 (Pubitemid 40591224)
17. CL Vandewalle MI Coeckelberghs IH De Leeuw, et al. 1997 Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment Diabetes Care 20 1556 1561 10.2337/diacare.20.10.1556 1:STN:280:DyaK2svmtVaisg%3D%3D 9314635
18. BJ Van der Auwera FC Schuit I Weets, et al. 2002 Relative and absolute HLA-DQA1-DQB1 linked risk for developing type I diabetes before 40 years of age in the Belgian population: implications for further prevention studies Hum Immunol 63 40 50 10.1016/S0198-8859(01)00362-7 11916169 (Pubitemid 34074635)
19. CL Vandewalle A Falorni S Svanholm, et al. 1995 High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years J Clin Endocrinol Metab 80 846 851 10.1210/jc.80.3.846 1:CAS:528:DyaK2MXktlOntL4%3D 7883841
20. AM Hämäläinen M Knip 2002 Autoimmunity and familial risk of type 1 diabetes Curr Diab Rep 2 347 353 10.1007/s11892-002-0025-2 12643195
21. MR Christie S Genovese D Cassidy, et al. 1994 Antibodies to islet 37 k antigen, but not to glutamate decarboxylase discriminate rapid progression to IDDM in endocrine autoimmunity Diabetes 43 1254 1259 10.2337/diabetes.43.10.1254 1:STN:280:DyaK2M%2FhtFSlsQ%3D%3D 7926297
22. P Achenbach V Lampasona U Landherr, et al. 2009 Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk Diabetologia 52 1881 1888 10.1007/s00125-009-1438-0 1:CAS:528:DC%2BD1MXpsFyrsrY%3D 19590848
23. M Solimena R Dirkx Jr JM Hermel, et al. 1996 ICA512, an autoantigen of type 1 diabetes, is an intrinsic membrane protein of neurosecretory granules EMBO J 15 2102 2114 1:CAS:528:DyaK28XjtFyjsbY%3D 8641276
24. C Wasmeier JC Hutton 1996 Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes J Biol Chem 271 18161 18170 10.1074/jbc.271.30.18161 1:CAS:528:DyaK28XksFyhsL4%3D 8663434 (Pubitemid 26250807)
25. F Chimienti S Devergnas A Favier M Seve 2004 Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules Diabetes 53 2330 2337 10.2337/diabetes.53.9.2330 1:CAS:528:DC%2BD2cXns1Shs7w%3D 15331542 (Pubitemid 39145586)
26. V Lampasona M Bearzatto S Genovese, et al. 1996 Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen J Immunol 157 2707 2711 1:CAS:528:DyaK28Xls1aiu74%3D 8805677
27. AL Notkins B Zhang Y Matsumoto MS Lan 1997 Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: Recognition of antigenic determinants by IDDM sera J Autoimmun 10 245 250 10.1006/jaut.1997.0132 1:STN:280:DyaK2szmtFOruw%3D%3D 9218750 (Pubitemid 27286530)
28. L Yu M Rewers R Gianani, et al. 1996 Antiislet autoantibodies usually develop sequentially rather than simultaneously J Clin Endocrinol Metab 81 4264 4267 10.1210/jc.81.12.4264 1:CAS:528:DyaK28XnsVKktL8%3D 8954025 (Pubitemid 26412027)
29. RDG Leslie M Delli Castelli 2004 Age-dependent influences on the origins of autoimmune diabetes: evidence and implications Diabetes 53 3033 3040 10.2337/diabetes.53.12.3033 1:CAS:528:DC%2BD2cXhtVOls7vE 15561931 (Pubitemid 39571713)
30. P Achenbach E Bonifacio K Koczwara AG Ziegler 2005 Natural history of type 1 diabetes Diabetes 54 Suppl 2 S25 S31 10.2337/diabetes.54.suppl-2.S25 1:CAS:528:DC%2BD2MXht12gs7jF 16306336 (Pubitemid 43343328)
31. I Truyen P De Pauw P Jørgensen, et al. 2007 Proinsulin level and proinsulin-to-C-peptide ratio complement autoantibody measurement for predicting type 1 diabetes Diabetologia 48 2322 2329 10.1007/s00125-005-1959-0
32. KC Herold W Hagopian JA Auger, et al. 2002 Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus N Engl J Med 346 1692 1698 10.1056/NEJMoa012864 1:CAS:528:DC%2BD38XktVansLY%3D 12037148 (Pubitemid 34547482)